In the News Press Releases In the News Media Contact September 24, 2021 1st Patient Dosed in Trial of IPF Therapy Candidate Taladegib January 7, 2021 Endeavor BioMedicines Raises $62 Million to Combat Pulmonary Disease January 7, 2021 Endeavor Launches with $62m and a Hedgehog Inhibitor from Lilly January 7, 2021 Serial Biotech Entrepreneur John Hood Raises $62 Million for Company Aimed at Deadly Lung Disease January 7, 2021 My Newest Puzzle, Endeavor BioMedicines, and the Chance to Reverse a Devastating Pulmonary Disease